These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22749801)

  • 21. Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity.
    Horsthuis K; Lavini C; Bipat S; Stokkers PC; Stoker J
    Radiology; 2009 May; 251(2):380-7. PubMed ID: 19401571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn's disease.
    Del Vescovo R; Sansoni I; Caviglia R; Ribolsi M; Perrone G; Leoncini E; Grasso RF; Cicala M; Zobel BB
    Abdom Imaging; 2008; 33(4):417-24. PubMed ID: 17639383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating the arterial input function from dynamic contrast-enhanced MRI data with compensation for flow enhancement (II): Applications in spine diagnostics and assessment of crohn's disease.
    van Schie JJN; Lavini C; van Vliet LJ; Kramer G; Pieters-van den Bos I; Marcus JT; Stoker J; Vos FM
    J Magn Reson Imaging; 2018 May; 47(5):1197-1204. PubMed ID: 29193469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn's disease.
    Florie J; Horsthuis K; Hommes DW; Nio CY; Reitsma JB; van Deventer SJ; Stoker J
    Clin Gastroenterol Hepatol; 2005 Dec; 3(12):1221-8. PubMed ID: 16361048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled echo sequence be sufficient for liver MR imaging?
    Coulam CH; Chan FP; Li KC
    AJR Am J Roentgenol; 2002 Feb; 178(2):335-41. PubMed ID: 11804888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility of evaluating Crohn's disease activity at 3.0 Tesla.
    van Gemert-Horsthuis K; Florie J; Hommes DW; Lavini C; Reitsma JB; van Deventer SJ; Stoker J
    J Magn Reson Imaging; 2006 Aug; 24(2):340-8. PubMed ID: 16786589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoscopy and magnetic resonance imaging in patients with Crohn's disease: a retrospective single-centre comparative study.
    Dinter DJ; Chakraborty A; Brade J; Back W; Neff KW; Singer MV; Böcker U
    Scand J Gastroenterol; 2008; 43(2):207-16. PubMed ID: 17918002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of criteria for the activity of Crohn's disease by power Doppler sonography.
    Neye H; Voderholzer W; Rickes S; Weber J; Wermke W; Lochs H
    Dig Dis; 2004; 22(1):67-72. PubMed ID: 15292697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT.
    Louis E; Ancion G; Colard A; Spote V; Belaiche J; Hustinx R
    J Nucl Med; 2007 Jul; 48(7):1053-9. PubMed ID: 17574978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective comparison of magnetic resonance imaging features and histopathology in Crohn's disease patients.
    Ziech ML; Bipat S; Roelofs JJ; Nio CY; Mearadji B; van Doorn S; Spijkerboer AM; Stoker J
    Eur J Radiol; 2011 Dec; 80(3):e299-305. PubMed ID: 21295932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crohn's disease. Pilot study comparing MRI of the abdomen with clinical evaluation.
    Kettritz U; Isaacs K; Warshauer DM; Semelka RC
    J Clin Gastroenterol; 1995 Oct; 21(3):249-53. PubMed ID: 8648064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffusion-weighted magnetic resonance imaging is effective to detect ileocolonic ulcerations in Crohn's disease.
    Buisson A; Hordonneau C; Goutte M; Boyer L; Pereira B; Bommelaer G
    Aliment Pharmacol Ther; 2015 Aug; 42(4):452-60. PubMed ID: 26088810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhanced MRI.
    Pupillo VA; Di Cesare E; Frieri G; Limbucci N; Tanga M; Masciocchi C
    Radiol Med; 2007 Sep; 112(6):798-809. PubMed ID: 17885739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hydro-MRI in inflammatory bowel diseases: a comparison with colonoscopy and histology].
    Schunk K; Reiter S; Kern A; Orth T; Wanitschke R
    Rofo; 2001 Aug; 173(8):731-8. PubMed ID: 11570244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index.
    Steward MJ; Punwani S; Proctor I; Adjei-Gyamfi Y; Chatterjee F; Bloom S; Novelli M; Halligan S; Rodriguez-Justo M; Taylor SA
    Eur J Radiol; 2012 Sep; 81(9):2080-8. PubMed ID: 21924572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic evaluation of chronic inflammatory intestinal diseases in children and adolescents: MRI with true-FISP as new gold standard?].
    Hohl C; Haage P; Krombach GA; Schmidt T; Ahaus M; Günther RW; Staatz G
    Rofo; 2005 Jun; 177(6):856-63. PubMed ID: 15902636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of gadolinium-based contrast agent in the assessment of Crohn's disease activity: Is contrast agent injection necessary?
    Quaia E; Sozzi M; Gennari AG; Pontello M; Angileri R; Cova MA
    J Magn Reson Imaging; 2016 Mar; 43(3):688-97. PubMed ID: 26250897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic contrast-enhanced MRI in determining disease activity in perianal fistulizing Crohn disease: a pilot study.
    Ziech ML; Lavini C; Bipat S; Ponsioen CY; Spijkerboer AM; Stokkers PC; Nederveen AJ; Stoker J
    AJR Am J Roentgenol; 2013 Feb; 200(2):W170-7. PubMed ID: 23345381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.